Webinar: Unlocking the secrets of muscular disease using iPSC models

Several disease models have contributed to advances in cardiac and neurological research. The development of new disease models is advancing iPSC differentiation techniques. As a result, more cell-relevant disease models are available to explore and allows us to unlock secrets of several diseases, including those for muscular diseases such as Duchenne's Muscular Dystrophy. 

Nevertheless, implementation of iPSC-derived models in drug discovery projects involves several critical considerations. For instance, lineage specification of iPSCs to cell types that closely recapitulate key disease features and cell manufacturing at a commercial scale. Another critical step is reproducibility and development of high-throughput assays that measure the disease biology.

During the webinar - "Unlocking the secrets of muscular disease using iPSC models" - our senior scientist stem cell technology Mariana Argenziano will discuss the advantages, challenges, and solutions of implementing iPSC-technology into drug discovery and development for muscle disease modeling.

In this webinar, you will learn about:

• The advantages of iPSC-derived muscle disease models

• The critical considerations when implementing iPSC-based models

• The iPSC-based model of Duchenne's Muscular Dystrophy and its advantages and challenges.